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Open access undeBackground: Obesity has been associated with breast cancer risk in the Caucasian population but
the association remains unclear in the Hispanics. Previous studies conducted among Hispanics in
the U.S. have shown inconsistent results.
Purpose: The association between anthropometry, body shape evolution across lifetime, and the
risk of breast cancer was assessed using a multi-center population-based case–control study
conducted in Mexico.
Methods: One thousand incident cases and 1074 matched control women aged 35–69 years were
recruited between 2004 and 2007, and analyzed in 2011–2012. Conditional logistic regression
models were used.
Results: Height was related to an increased risk of breast cancer in both premenopausal
(p trend¼0.03) and postmenopausal women (p trend¼0.002). In premenopausal women, increase
in BMI; waist circumference (WC); hip circumference (HC); and waist–hip ratio (WHR) were
inversely associated with breast cancer risk (p trendso0.001 for BMI and WC, 0.003 for HC, and
0.016 for WHR). In postmenopausal women, decreased risks were observed for increased WC
(p trend¼0.004) and HC (p trend¼0.009) among women with time since menopause o10 years.
Further analysis of body shape evolution throughout life showed strong and signiﬁcant increase in
risk of breast cancer among women with increasing silhouettes size over time compared to women
with no or limited increase.
Conclusions: These ﬁndings suggest that anthropometric factors may have different associations
with breast cancer risk in Hispanic women than in Caucasian women. This study also shows the
importance of considering the evolution of body shape throughout life.
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r CC BY-NC-ND license.IntroductionBreast cancer is a rapidly growing challenge forglobal health, particularly in developing countrieswhere close to 70% of world breast cancer deaths
occur.1 In 2010, Mexico alone was estimated to have
about 14,000 new cases of breast cancer, with an age-
standardized rate (ASR) of 27.2.2
Demographic and behavioral factors could contribute
to the rising incidence of breast cancer in Mexico. Mexico
has experienced a spectacular increase of obesity in the
last 15 years. In 1989, less than 34% of Mexican adults
were overweight, whereas more than 71% of Mexican
women are currently overweight and about 35% of
women are obese.3lsevier Inc. on behalf of American Journal of Preventive Medicine
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of many studies and has been associated with breast
cancer risk with opposite effects in pre- and post-
menopausal women.4–8 Height9–11 and waist–hip ratio
(WHR)12–15 have also been associated with an increase
risk in both pre- and post-menopausal women. Recent
epidemiologic studies have suggested an association
between body size and weight gain through lifetime
and breast cancer risk. Indeed, some studies reported that
obesity (BMI Z30); higher relative weight; and heavy
body build in childhood or adolescence are associated
with a decreased risk of pre- and post-menopausal breast
cancer.16–21 However, these studies were conducted
mainly in Caucasian women.
Previous studies conducted amongHispanic women living
in the U.S. have shown different patterns. Some studies
reported inverse associations19,22 between obesity (BMIZ30
kg/m²) and breast cancer, whereas others found no associ-
ations.23 A recent review study conducted in Hispanics living
in the U.S. concluded that the effect of obesity on breast
cancer risk is inconsistent.24 To our knowledge, no study on
the association between anthropometric factors, their mod-
iﬁcations over lifetime, and breast cancer risk has been
conducted among Mexican women living in Mexico. Given
the high prevalence of obesity in Mexican women and the
emergence of a remarkably high prevalence of obesity in
children,25 it becomes essential to assess whether body shape
(silhouette) at young ages or body shape evolution through
life could be associated with breast cancer risk. Our
hypotheses were that (1) current anthropometric measures;
(2) body shape at different ages; and (3) body shape evolution
across lifetime (body shape trajectories) are associated with
breast cancer risk in pre- and post-menopausal Mexican
women. Therefore, data from a multi-center population-
based case–control study conducted in Mexico were used to
assess these associations.Methods
Study Population
The CAMA (cancer [CA] de mama [MA]) study is a multi-center
population-based case–control study of breast cancer conducted
by the National Institute of Public Health in Cuernavaca, Mexico.
In this study, 1000 women aged 35–69 years (cases) and 1074
matched population control women were recruited between
January 2004 and December 2007 from three regions in Mexico
(Mexico City, Monterrey, and Veracruz). The design of the study
has already been presented.26,27 Brieﬂy, cases were identiﬁed by
trained ﬁeld staff at 12 hospitals from the major healthcare
institutions in Mexico: the Mexican Institute of Social Security
(Instituto Mexicano del Seguro Social, IMSS, six hospitals); the
Social Security and Services Institute for State Employees (Instituto
de Seguridad y Servicios Sociales de los Trabajadores del EstadoMarch 2014[ISSSTE], two hospitals); and the Ministry of Health (Secretaríade
Salud [SS], four hospitals).
The cases were included according to the following criteria:
women who (1) had a new histologically conﬁrmed diagnosis of
breast cancer; (2) were not treated with radiotherapy, chemo-
therapy, or antiestrogens during the previous 6 months; (3) were
not currently using aromatase inhibitors; and (4) were not
pregnant. The response rate for cases was 95.5% for Mexico City,
94.4% for Monterrey, and 97.4% for Veracruz. Controls were
selected based on a probabilistic multistage design as described
elsewhere26,27 and were frequency-matched to the cases, according
to 5-year age groups, healthcare institution, and region. They were
enrolled at approximately the same time as the breast cancer
diagnoses. The response rate for controls was 87.4% for Mexico
City, 90.1% for Monterrey, and 97.6% for Veracruz.
Women (cases and controls) who agreed to participate signed
an informed consent form and participated in a face-to-face
interview. The study was approved by the IRB of the Instituto
Nacional de Salud Publica (INSP) and the Instituto Mexicano de
Seguridad Social (IMSS).
Data Collection
Trained nurses based at each hospital conducted in-person interviews
with the cases close to their date of diagnosis (median=3 days).
Among controls, trained nurses administered a questionnaire and
scheduled an appointment for a hospital visit during which anthro-
pometric measurements were obtained, mammography screening was
performed, and a blood sample was taken. The questionnaire included
information on sociodemographic characteristics; reproductive history
(e.g., age at menarche and menopause, parity, and breast feeding
history); dietary intake; physical activity; use of hormone contra-
ceptives and hormone replacement therapy for menopause; family
history of breast cancer; alcohol consumption; and smoking history.
Dietary information was obtained by asking women about their food
consumption the year prior to the onset of the symptoms, using
a separate 104-item semi-quantitative Food Frequency Questionnaire
(FFQ), based on consumption data from women living in Mexico
City using methods described and used by Willett.28 Fasting blood
samples were obtained from all of the case and control subjects at
recruitment.
Anthropometric Measures
Anthropometric indices were measured by nurses trained at
recruitment according to Lohamn’s recommendations.29 Body
weight was measured in subjects using a digital electronic scale
(Tanita) and registered at nearest 0.1 kg. Standing height was
measured with a stadiometer (SECA, Hamburg, Germany) to the
nearest millimeter. Waist circumference (WC) was measured in
supine position at the umbilicus level and hip circumference in
standing position at the level of the most prominent part of the
gluteus. BMI was calculated as weight (in kilograms) divided by
height (in meters) squared. WHR was calculated based on waist (in
centimeters) divided by a hip circumference (in centimeters).
Based on equally spaced boundaries and the sample size, height;
WC; hip circumference (HC); and WHR were grouped into
three categories as follows: height (o150, 150–154.9, and
Z155 cm); HC (o103, 103–112, and Z112 cm); WC (o93,
93–103, and Z103 cm); and WHR (o0.85, 0.85–0.93,
Amadou et al / Am J Prev Med 2014;46(3S1):S52–S64S54and Z0.93). BMI was used as categorical variable by using
international cut-off points of o25 as normal, 25–29.9 as over-
weight, and Z30 as obese.
Body Shape at Different Ages
Women were asked to select the silhouette that best represented
their body shape (using six pictograms representing body shapes
ranging from lean to large) at six different ages: childhood (aged
6–11 years); adolescence (aged 12–18 years); aged 18–20 years;
before ﬁrst pregnancy; aged 25–35 years; and at current age
(Figure 1). Responses to these pictograms have been validated in
different settings and have proven to be reliable.30 In this study,
Pearson correlation between recalled current body fatness and
current BMI was 0.70. In order to have enough subjects in each
category for the statistical analyses, the six silhouettes were
combined in categories as follows: for silhouette at childhood, at
adolescence, at age 18–20 years, and at age before ﬁrst pregnancy:
lean¼Figure 1; medium¼Figure 2; and large¼Figures 3þ4þ5þ6.
For body silhouette at age 25–35 years and current silhouette:
lean¼Figures 1þ2; medium¼Figure 3, and large¼Figures 4þ5þ6.
Statistical Analysis
Demographic and other potential confounders were compared
between cases and controls by using t test for continuous variables
and chi-square test for categorical data. Conditional logistic
regression models were used to examine the association between
anthropometric measures, body silhouette at different ages and
changes in silhouette. Multivariate adjusted ORs and correspond-
ing 95% CIs were estimated, adjusting for age (o40, 40–54, 55–64,
Z65 years); healthcare system; region; SES (high/medium/low);
breast feeding (months, yes/no); age at ﬁrst pregnancy (years,
continuous); parity (continuous); family history of breast cancer
(FHBC, yes/no); alcohol consumption (yes/no); physical activity
(o250, 250–300, Z300 METs per week); calorie intake (o1750,
1750–2500, Z2500 kcal per day); and height (continuous).
The variable height was not adjusted for when height was the0
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Figure 1. Frequency distribution of Mexican women by perce
silhouette (ranging from lean to large) at six different ages, CAM
2007
Note: childhood: aged 6–11 years; adolescence: aged 12–18 yearsexposure of interest. SES index was deﬁned based on belongings
(i.e., gas or electric stove, water heating system, radio or cassette
recorder, television, videocassette recorder, CD player, refrigerator,
washing machine, microwave oven, blender, vacuum cleaner,
water pump, motorcycle, car or van, land phone, cellular phone,
computer, and dish antenna). This index was constructed by
means of principal components analysis26; tertiles were generated
based on distribution among controls (low, medium, and high
SES). In postmenopausal women, additionally adjusted by age at
menopause (r45 and 446 years), and hormone replacement
therapy (HRT) (ever/never) were done.
Stratiﬁed analyses. Analyses were conducted separately for
pre- and post-menopausal women. Separate analyses were also
performed adjusting for and then stratifying by current BMI (o29
and Z29) given that the mean value of BMI is 29 in the study
population. In addition, a stratiﬁed analysis was conducted
according to age at ﬁrst full-term pregnancy (o22 orZ22 years)
and number of pregnancy (o3 orZ3). These cut-off points were
decided a priori in order to categorize women with a more “high-
income countries type of reproductive pattern” or a more “middle-
to low-income countries type of reproductive pattern.”
Silhouettes analysis. SAS PROC TRAJ (automatic proce-
dures) was used to estimate the different groups of body shape
evolution throughout life (trajectory) on the basis of six body shapes
at different ages.18,31,32 This procedure is a discrete mixture model
that models the trajectory or pattern of change over time
in multiple subgroups within the population. The best number of
groups and shapes of trajectories were selected based on the
Bayesian information criterion (BIC) and the percentage of indi-
viduals included in each category.32,33 Estimation of body shape
trajectory throughout life was performed using a quadratic and
cubic function of age for each trajectory. Accordingly, ﬁve distinct
silhouette trends (trajectories) were estimated. All analyses were
conducted using Stata (version 11) and SAS (version 9.3). All
p-values were two-sided.en
ears
Age at
recruitment
ived body shape
A, Mexico, 2004–Results
Population Characteristics
Table 1 presents the general character-
istics of cases and controls according to
menopausal status. One thousand cases
(415 premenopausal and 585 postme-
nopausal women) and 1074 controls
(476 premenopausal and 598 postme-
nopausal women) were included in
the study. Compared to controls, cases
were more likely to have their ﬁrst full-
term pregnancy after age 22 years in
premenopausal women (po0.001) and
postmenopausal women (po0.001).
Caloric intake and alcohol consump-
tion were higher in both pre- and
post-menopausal cases than controls
(po0.001).www.ajpmonline.org
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Cancer Risk
Among premenopausal women, height was associated
with an increased risk, with the greatest increase in risk
observed among women of height Z155 compared to
those of o150 cm (OR¼1.48, 95% CI¼1.03, 2.13;
p trend¼0.027). Breast cancer risk was inversely asso-
ciated with BMI, WC, HC, and WHR (p trendso0.001
for BMI and WC, 0.003 for HC, and 0.016 for WHR).
Further adjustment for current BMI did not affect
signiﬁcantly the positive association with height and
the inverse association of WC, whereas the inverse asso-
ciations of HC, WHR, and waist/height were attenuated
(Table 2).
Among postmenopausal women, a signiﬁcant increase
in breast cancer risk was observed for height
(p trend¼0.002), whereas a decreased risk was observed
for increased WC (p trend¼0.003); WHR (p trend¼
0.003); and HC (p trend¼0.046) (Table 2). When
stratiﬁed by HRT use, similar results were found among
non-users (data not shown). Further analyses stratifying
by age at ﬁrst full-term pregnancy and parity did not
substantially change the results in either pre- or post-
menopausal women (data not shown). The effect of
time since menopause was investigated by stratifying into
two groups (o10 and Z10 years). For time since
menopause o10 years, signiﬁcant decreased risk were
found for increased HC (p trend¼0.009) and WC
(p trend¼0.004) whereas no decreased risk was observed
in women with time since menopause 410 years
(Table 3).Body Shape at Different Ages and Breast
Cancer Risk
At childhood, 55.6% of the women classiﬁed their
silhouette as Level 1 (lean) and only 3.95% as Level
Z4. In contrast, 62.77% of women reported a current
silhouette of Level Z4 and only 1.93% as Level 1.
Figure 1 illustrates the change of silhouette over time,
reﬂecting weight gain. No clear effect on breast cancer
risk was observed with silhouette at different ages,
except for current silhouette in premenopausal women
(p trend¼0.005) (data not shown). Further analysis was
done to examine the association of silhouette at different
ages and breast cancer risk stratifying by age at ﬁrst full-
term pregnancy and parity (Table 4). Among women
who had their ﬁrst full-term pregnancy before age
22 years and with Z3 children, a strong inverse
association was observed between a large silhouette at
age 18–20 and risk of breast cancer in premenopausal
women (OR¼0.33; 95% CI¼0.15, 0.72; p trend¼0.001).
Among postmenopausal women, a decreasing trendMarch 2014in risk was observed in relation to a larger silhouette
in childhood (OR¼0.47, 95% CI¼0.25, 0.90;
p trend¼0.023) (Table 4).
Body Shape Trajectory and Breast Cancer Risk
With regard to body shape evolution throughout life,
overall, ﬁve distinct trajectories were estimated with at
least 3% of the population in each category (Figure 2).
The ﬁrst trajectory (Group 1: constantly low) was
constantly low from age 8 years (childhood) to age
20 years and then increased only slightly. This group
represented 14.4% of the study population. The second
trajectory (Group 2: constantly mid-range) showed no or
only minimal changes over time, with an estimated
population proportion of 40.3%. The third trajectory
(Group 3: moderate increase) showed a clear increase in
body shape from age 13 (adolescence), with an estimated
population proportion of 20.3%. The fourth group
(Group 4: strong increase) showed a strong increase with
age to end up at the highest level of body shape in the
population by age 30 years. It constituted 21.9% of the
study population. Finally, the ﬁfth trajectory (Group 5:
constantly high) started with high body shape at age 8
(childhood) and remained high over the age periods. This
group represented 3.2% of the study population.
Among all women combined, a signiﬁcant increase in risk
was observed for all trajectories except the Trajectory 5
(constantly high) as compared to Trajectory 1 (Table 5).
Among premenopausal women, a strong increase in silhou-
ette (Trajectory 4) from childhood onwards was marginally
associated with an increased risk for premenopausal breast
cancer (OR¼1.65; 95% CI¼0.98, 2.75). Among postmeno-
pausal women, the multivariate ORs were 1.55 (95%
CI¼1.05, 2.29) for women in Trajectory 2 and 1.71 (95%
CI¼1.10, 2.67) for women in Trajectory 3 (Table 5).
Discussion
In the present study, an association with height was
observed in both pre- and post-menopausal women and
the risk for breast cancer. In premenopausal women,
inverse associations were observed between BMI, WC,
HC, and WHR and the risk for breast cancer; among
postmenopausal women, similar inverse associations
were found for WC, HC, and WHR but this association
decreased with time since menopause. Evaluation of the
impact of the body shape trajectory showed that increas-
ing silhouettes over time was associated with increasing
risk of breast cancer.
Anthropometric Measures
These ﬁndings conﬁrm those from previous studies that
have shown positive association between height and
Table 1. Characteristics of population cases and controls according to menopausal status, 2004–2007, n (%)
Premenopausal Postmenopausal
Cases Controls Cases Controls
(n¼415
[47%])
(n¼476
[53%]) p-valuea
(n¼585
[49%])
(n¼598
[51%]) p-valuea
Age (years) 0.695 0.014
o40 255 (61) 303 (63) 15 (3) 25 (4)
40–54 156 (38) 167 (35) 188 (32) 205 (34)
55–64 4 (1) 5 (1) 259 (44) 282 (47)
Z65 0 (0) 1 (0) 123 (21) 86 (14)
Ever use of oral contraceptive 0.637 0.760
No 214 (52) 253 (63) 337 (58) 341 (57)
Yes 201 (48) 223 (47) 245 (42) 257 (43)
Age at menarche 0.553 0.505
o13 194 (47) 232 (49) 241 (41) 235 (39)
Z13 221 (53) 244 (51) 344 (59) 363 (61)
Family history of breast cancer 0.521 0.002
No 390 (94) 452 (95) 547 (94) 582 (97)
Yes 25 (6) 24 (5) 38 (6) 16 (3)
SES 0.363 o0.001
Low 127 (31) 142 (30) 179 (31) 217 (36)
Medium 115 (28) 152 (32) 146 (25) 205 (34)
High 173 (42) 182 (38) 260 (44) 176 (29)
Age at 1st full-term pregnancy o0.001 o0.001
Nulliparous 45 (11) 40 (8) 71 (12) 27 (5)
o22 169 (41) 261 (54) 240 (41) 343 (57)
Z22 191 (46) 174 (37) 259 (44) 221 (37)
Age at menopause (years) 0.319
r45 150 (26) 141 (24)
446 416 (71) 440 (73)
Missing 19 (3) 17 (3)
Ever use of hormonal replacement therapy o0.001
No 446 (76) 510 (85)
Yes 134 (23) 87 (15)
Physical activity (METs per week) 0.091 o0.001
o250 116 (28) 136 (29) 254 (43) 208 (35)
250–300 200 (48) 199 (42) 261 (45) 245 (41)
Z300 99 (24) 141 (30) 70 (12) 145 (24)
(continued on next page)
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Table 1. (continued)
Premenopausal Postmenopausal
Cases Controls Cases Controls
(n¼415
[47%])
(n¼476
[53%]) p-valuea
(n¼585
[49%])
(n¼598
[51%]) p-valuea
Number of full-term pregnancies 0.125 o0.001
0 45 (11) 40 (8) 71 (12) 27 (5)
12 176 (42) 178 (37) 162 (28) 126 (21)
Z3 193 (47) 255 (54) 346 (59) 445 (74)
Breast feeding 0.925 0.03
Nulliparous 45 (11) 40 (8) 71 (12) 27 (5)
o12 months 46 (11) 46 (10) 75 (13) 56 (9)
Z12 months 136 (33) 130 (27) 136 (23) 98 (16)
Missing 188 (45) 260 (55) 303 (52) 417 (70)
Alcohol o0.001 0.001
No 301 (73) 405 (85) 467 (80) 523 (87)
Yes 89 (21) 60 (10) 87 (15) 52 (9)
Missing 25 (6) 11 (5) 31 (5) 23 (4)
Caloric intake (kcal per day) o0.001 o0.001
o1750 107 (26) 186 (39) 180 (31) 273 (46)
1750–2500 156 (38) 160 (34) 214 (37) 191 (32)
Z2500 152 (37) 130 (24) 191 (33) 134 (22)
BMIb 27.85.1 29.25.3 o0.001 29.135.8 30.255.5 0.009
Waist–hip ratiob 0.890.08 0.900.1 0.012 0.910.1 0.900.09 0.379
Heightb 154.56.1 153.55.7 0.037 152.17.5 150.56.4 0.003
Waist circumferenceb 92.213.8 9614.2 o0.001 96.914.1 99.413.6 0.002
Hip circumferenceb 104.0712.7 106.313.8 0.001 106.0113.6 108.313.3 0.015
Weightb 66.112.8 68.614 o0.001 6713.6 68.213.4 0.209
ap-value: t test for continuous variables and chi-square test for categorical variables
bmedianþ standard error
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The inverse relationship between BMI and breast cancer
in premenopausal women is consistent with many
previous ﬁndings mostly in Caucasian women.7,11 A
dose–response meta-analysis on BMI and premeno-
pausal breast cancer has reported an overall risk estimate
of 0.92 (95% CI=0.88, 0.97) for each increment of 5.7
Similarly, a case–control study conducted in Hispanic
women living in the U.S. concluded that high BMI at age
30 years was associated with a decrease of the risk of
premenopausal breast cancer (OR¼0.46, 95% CI¼0.25,
0.84; for BMI 430 vs o25).34 For postmenopausal
women, the lack of signiﬁcant association between BMI
and breast cancer is at variance with studies conducted inMarch 2014Western populations.6–8,11,35 Of note, several studies
conducted among Hispanic populations in the U.S. have
reported inconsistent associations between BMI and risk
of breast cancer in postmenopausal women.23,24,36
The results of decreased risk of pre- and post-
menopausal breast cancer with increased WC, HC, and
WHR are at variance with most previous studies con-
ducted in high-resource countries.12–14,37,38 Of note, in
this study anthropometric measurements were con-
ducted by trained health workers and repeated (/ check),
thus limiting the impact of measurement errors. Thus,
this difference may reﬂect the characteristics of this
Hispanic population, which include few women who
remain lean over their lifetime. Alternatively, it may
Table 2. Association between body size measures and breast cancer risk in Mexican women by menopausal status, 2004–2007
Premenopausal women Postmenopausal women
Cases
(n¼415)
Controls
(n¼476) OR (95% CI)a OR (95% CI)b
Cases
(n¼583)
Controls
(n¼598) OR (95% CI)a OR (95% CI)b
BMI
o25 100 74 1 89 71 1
25–29.9 182 200 0.72 (0.49, 1.05) 239 213 0.96 (0.64, 1.44)
Z30 133 202 0.48 (0.32, 0.72) 257 314 0.75 (0.51, 1.12)
p trend o0.001 0.068
Height (cm)
o150 87 124 1 1 204 273 1 1
150–154.9 132 163 1.13 (0.78, 1.65) 1.02 (0.76, 1.64) 181 181 1.30 (0.96, 1.76) 1.28 (0.94, 1.74)
Z155 196 189 1.48 (1.03, 2.13) 1.47 (1.02, 2.12) 200 144 2.00 (1.45, 2.75) 1.98 (1.43, 2.74)
p trend 0.027 0.030 0.002 o0.001
Waist circumference (cm)
o93 214 173 1 1 187 169 1 1
93–103 122 165 0.60 (0.43, 0.85) 0.64 (0.44, 0.93) 218 193 0.96 (0.70, 1.32) 0.96 (0.68, 1.37)
Z103 79 138 0.42 (0.29, 0.61) 0.45 (0.27, 0.74) 180 236 0.62 (0.44, 0.85) 0.62 (0.40, 0.95)
p trend o0.001 0.001 0.003 0.024
Hip circumference (cm)
o103 179 163 1 1 210 181 1 1
103–112 129 159 0.67 (0.48, 0.94) 0.82 (0.55, 1.22) 186 188 0.87 (0.63, 1.20) 0.91 (0.63, 1.33)
Z112 107 154 0.58 (0.40, 0.83) 0.87 (0.52, 1.48) 189 229 0.72 (0.52, 0.99) 0.81 (0.50, 1.32)
p trend 0.003 0.573 0.046 0.414
(continued on next page)
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March 2014reﬂect different effects of fat accumulation and distribu-
tion in this Hispanic population compared to popula-
tions in high-resource countries. Several studies
conducted among Hispanic women in the U.S. suggested
inverse associations similar to the ones reported
here.22,34,39 More recently, a study conducted in a
multiethnic U.S. population showed nonsigniﬁcant
inverse associations between WHR, WC, and breast
cancer risk among Hispanic women (ORs=0.71, 95%
CI=0.46, 1.11, for WHR 40.85 vs r0.77; 0.74, 95%
CI=0.47, 1.17 for WC498 cm vsr78.7 cm).19 Overall,
these ﬁndings suggest that anthropometric factors may
have different associations with breast cancer risk in
Hispanic women than among Caucasian women, per-
haps because of ethnic variations in body fat distribution.
These results may also be related to the relative young age
of postmenopausal women in this study. When data were
stratiﬁed by time since menopause, the inverse associa-
tion was observed only among women with time since
menopause o10 years.Body Shape at Different Ages
To date, few studies have examined the relationship
between body silhouettes at young ages and breast cancer
risk in Hispanic women and none among Mexican
women. Consistent with these results, Sangaramoorthy39
reported suggestive inverse associations of body silhou-
ette at ages 10 and 15 years in pre- and post-menopausal
Hispanic women. In contrast signiﬁcant inverse associ-
ations were observed when compared heavier versus
lighter weight (p trend¼0.005 at age 10 years,o0.001 at
age 15 years, and 0.002 at age 20).39 Only one study
found that heavy body silhouette compared to lean at
current age was associated with a decreased risk of breast
cancer (p trendo0.01).19,34 However, several other
studies mainly conducted in Western countries demon-
strated that greater body fatness (BMI, weight) at young
ages was associated with lower breast cancer risk in both
premenopausal women6,16,17,34,40 and postmenopausal
women.6,40,41Body Shape Trajectory
The results on trajectories of body shape showed strong
and signiﬁcant increase in risk of breast cancer among
women who increased silhouettes over time compared to
women with no or limited increase. Data on body shape
evolution and breast cancer risk are limited; in contrast
weight gain has been found to be associated with breast
cancer risk.23,42 Despite the high correlation of the
differentiation of body shape over time,20,43 silhouettes
are often studied at a speciﬁc age point. These ﬁndings
show the importance to consider the evolution of
Table 3. Association between body size measures and breast cancer in postmenopausal Mexican women according to time since menopause, 2004–2007
Time since menopause o10 years Time since menopause Z10 years
Cases Controls OR (95% CI)a OR (95% CI)b Cases Controls OR (95% CI)a OR (95% CI)b
BMI
o25 46 39 1 1
25–29.9 113 109 0.96 (0.53, 1.73) 43 32 0.71 (0.38, 1.36)
Z30 129 167 0.69 (0.38, 1.23) 126 104 0.57 (0.30, 1.09)
p trend 0.112 128 147 0.080
Height (cm)
o150 90 133 1 1 114 140 1 1
150–154.9 90 92 1.35 (0.85, 2.14) 1.34 (0.84, 2.13) 91 89 1.07 (0.68, 1.69) 1.05 (0.67, 1.65)
Z155 108 90 1.67 (1.05, 2.65) 1.66 (1.04, 2.63) 92 54 2.02 (1.20, 3.42) 1.99 (1.17, 3.37)
p trend 0.029 0.031 0.015 0.019
Waist circumference (cm)
o93 110 93 1 1 77 76 1 1
93–103 103 105 0.71 (0.45, 1.13) 0.69 (0.41, 1.16) 115 88 1.31 (0.79, 2.17) 1.54 (0.88, 2.68)
Z103 75 117 0.49 (0.30, 0.79) 0.46 (0.25, 0.86) 105 119 0.78 (0.47, 1.30) 1.07 (0.55, 2.10)
p trend 0.004 0.015 0.259 0.03
Hip circumference (cm)
o103 111 98 1 1 99 83 1 1
103–112 98 96 0.92 (0.58, 1.46) 0.88 (0.51, 1.51) 88 92 0.69 (0.42, 1.15) 0.87 (0.48, 1.56)
Z112 79 121 0.51 (0.31, 0.84) 0.47 (0.23, 0.96) 110 108 0.76 (0.46, 1.24) 1.16 (0.55, 2.45)
p trend 0.009 0.034 0.310 0.634
Waist-to-hip ratio
o0.85 56 52 1 1 54 37 1 1
0.85–0.93 131 145 0.76 (0.45, 1.28) 0.79 (0.47, 1.33) 111 109 0.77 (0.42, 1.39) 0.77 (0.42, 1.41)
Z0.93 101 118 0.61 (0.34, 1.07) 0.64 (0.36, 1.13) 132 137 0.56 (0.30, 1.04) 0.57 (0.30, 1.05)
p trend 0.089 0.126 0.054 0.055
Note: Bold values indicate p-valueo0.05.
aORs and 95% CIs adjusted for age, healthcare system, region, SES, breast feeding, age at ﬁrst pregnancy, parity, family history of breast cancer, alcohol consumption, physical activity, total calories
intake, height, and current BMI
bAdditional adjustment for current BMI
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Table 4. Association between body silhouette and breast cancer in Mexican women by menopausal status and current BMI, 2004–2007
Premenopausal women Postmenopausal women
Age at FFTP o22 and n-FTP Z3 Age at FFTP Z22 and n-FTP o3 Age at FFTP o22 and n-FTP Z3 Age at FFTP Z22 and n-FTP o3
Cases/controls OR (95% CI)a Cases/controls OR (95% CI)a Cases/controls OR (95% CI)a Cases/controls OR (95% CI)a
Silhouette at childhood
Lean 79/107 1 63/60 1 134/173 1 69/58 1
Medium 34/45 1.00 (0.56, 1.80) 56/25 3.39 (1.62, 7.08) 52/86 0.78 (0.47, 1.28) 43/15 2.60 (1.14, 5.89)
Large 19/40 0.68 (0.33, 1.39) 20/24 1.03 (0.44, 2.42) 22/45 0.47 (0.25, 0.90) 17/14 0.92 (0.35, 2.42)
p trend 0.373 0.2093 0.023 0.449
Silhouette at adolescent
Lean 52/65 1 41/42 1 85/124 1 47/37 1
Medium 51/78 0.66 (0.36, 1.17) 60/37 1.47 (0.72, 2.98) 83/112 0.95 (0.59, 1.53) 57/35 1.27 (0.60, 2.66)
Large 29/49 0.65 (0.33, 1.28) 38/30 1.36 (0.63, 2.96) 40/68 0.71 (0.40, 1.26) 25/15 1.49 (0.58, 3.77)
p trend 0.181 0.376 0.285 0.372
Silhouette at age 18–20 years
Lean 26/24 1 23/23 1 30/50 1 26/19 1
Medium 63/70 1.03 (0.49, 2.18) 64/45 1.30 (0.58, 2.93) 107/136 2.27 (1.21, 4.26) 68/46 1.22 (0.50, 2.96)
Large 43/98 0.33 (0.15, 0.72) 52/41 1.14 (0.49, 2.65) 71/118 1.37 (0.71, 2.62) 35/22 1.16 (0.41, 3.23)
p trend 0.001 0.856 0.884 0.807
Note: Bold values indicate p-value o0.05.
aORs and 95% CIs adjusted for age, healthcare system, region, SES, breast feeding, age at ﬁrst pregnancy, parity, family history of breast cancer, alcohol consumption, physical activity, total calories
intake, height, and current BMI
FFTP, ﬁrst full-term pregnancy; n-FTP, number of full-term pregnancies
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Group 5: constantly high (3.2%) 
Group 4: strong increase (21.9%) 
Group 3: moderate increase (20.3%) 
Group 2: constantly mid-range (40.3%) 
Group 1: constantly low (14.4%) 
Figure 2. Body shape trajectories throughout life and
estimates group patterns in all women, CAMA, Mexico,
2004–2007
Note: Five distinct trajectories were estimated: Group 1, constantly low;
Group 2, constantly mid-range; Group 3, moderate increase; Group 4,
strong increase; and Group 5, constantly high.
Amadou et al / Am J Prev Med 2014;46(3S1):S52–S64S62body shape throughout life instead of individual age
points when studying the effect of obesity on breast
cancer. Interestingly, this procedure of analysis esti-
mates multiple groups of patterns within the popula-
tion in contrast to a traditional regression or growth
curve model that models only one mean within the
population.
Potential Biological Mechanisms
Biological mechanisms linking body size and breast
cancer risk in minority women, in particular in Hispanic
populations, are not well documented, and it is possibleTable 5. Association between body shape trajectories and brea
women, 2004–2007
All women Prem
Trajectoriesa
Cases/
controls OR (95% CI)b
Cases/
controls
Group 1 173/150 1.00 61/69
Group 2 392/404 1.50 (1.12, 2.01) 164/171
Group 3 231/191 1.52 (1.09, 2.12) 72/102
Group 4 241/223 1.56 (1.11, 2.17) 109/112
Group 5 37/32 1.57 (0.86, 2.88) 9/22
Note: Bold values indicate po0.05.
aGroup 1, constantly low; Group 2, constantly mid-range; Group 3, moderat
bORs and 95% CIs adjusted for age, healthcare system, region, SES, breas
alcohol consumption, physical activity, total calories intake, height, and cuthat the effects of obesity at young ages and adulthood on
breast cancer risk differ between ethnic groups. Among
the few studies based on biological mechanisms, signiﬁ-
cantly higher levels of estrogens have been reported in
postmenopausal Hispanic women compared with non-
Hispanics,44 whereas another found no signiﬁcant differ-
ence in endogenous concentration levels between His-
panic and non-Hispanic women.45 In contrast, in
Caucasian it has been demonstrated among postmeno-
pausal women that obesity increases levels of circulating
endogenous sex hormones, insulin and insulin-like
growth factor (IGF-I). Of note, IGF-I may be the under-
lying factor for the association between height and risk of
breast cancer.46–50 Obesity also induces chronic low-grade
inﬂammation resulting in an increase of local and systemic
levels of cytokines. These factors may, in turn, affect
mitosis, apoptosis, cell senescence, and angiogenesis.46
Together, these hormonal effects and effects on metabo-
lism could facilitate tumor-promoting effects associated
with increasing body shape silhouette throughout the life
and breast cancer risk. With respect to possible protective
biological mechanisms, it has been postulated that in
premenopausal women, estradiol and progesterone levels
are reduced in anovulatory cycles that occur more
frequently in obese than in lean women.23 These two
hormonal effects could reduce the hormone-dependent
tumor-promoting growth in overweight and/or obese
women, accounting in part for the negative association
between current anthropometric measures (BMI, WC,
HC, and WHR) and risk of breast cancer observed in
premenopausal women.Advantages and Limitations
To our knowledge, this study is the largest population-
based case–control of anthropometric factors and breastst cancer risk in all, pre- and post-menopausal Mexican
enopausal women Postmenopausal women
OR (95% CI)b
Cases/
controls OR (95% CI)b
1.00 89/104 1.00
1.31 (0.83, 2.08) 240/221 1.55 (1.05, 2.29)
1.28 (0.76, 2.14) 119/129 1.71 (1.10, 2.67)
1.65 (0.98, 2.75) 114/129 1.46 (0.93, 2.29)
0.83 (0.30, 2.28) 23/15 2.20 (0.98, 4.94)
e increase; Group 4, strong increase; Group 5, constantly high
t feeding, age at ﬁrst pregnancy, parity, family history of breast cancer,
rrent BMI
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Amadou et al / Am J Prev Med 2014;46(3S1):S52–S64 S63cancer in Hispanic population outside the U.S. (in Latin
America), thus providing sufﬁcient power to assess these
associations. A strength of this study is that body size
(weight, height, WC, and HC) were measured twice by
nurses rather than self-reported, thus enhancing the
validity of measurement. Another strong point of the
study is that the self-reported current body silhouette had
a good correlation with measured BMI. However, women
might have misrecalled their body silhouette at different
ages although the somatotype pictogram has been
validated and shown to perform well.23,51 As with any
case–control study, cases and controls may recall certain
exposures differently; especially exposures related to
breast cancer. However, in this population, knowledge
about potential risk factors for breast cancer is low.
Nurses knew the status of cases and controls but there is
no reason to believe that they would have measured or
report differently anthropometric measures. (It should be
noted that we could not exclude the possible lack of
power in some stratiﬁed analyses, given the small sample
size in some of the subgroups.)
In summary, the ﬁndings of inverse associations
between high BMI, heavy silhouette at current age, and
breast cancer risk among premenopausal women con-
ﬁrm those from previous reports. In contrast with results
observed among Caucasians, anthropometric measures
(WC, HC, and WHR) were inversely related to breast
cancer risk among postmenopausal women. However,
increase of silhouette from childhood throughout life
showed strong and signiﬁcant increase in risk of breast
cancer, demonstrating the importance to take into
account the evolution of body shape with age. It will be
important to develop strict recommendations to main-
tain a normal weight and avoid increasing silhouette
across the life span.This study and publication of the article were ﬁnancially
supported by the Mexican National Council of Science and
Technology (CONACyT in Spanish; SALUD 2002-C01–7462).
The publication of this supplement was made possible
through the CDC and the Association for Prevention Teaching
and Research (APTR) Cooperative Agreement No. 1
U360E000005-01. The ﬁndings and conclusions in this report
are those of the authors and do not necessarily represent the
ofﬁcial position of the CDC or the APTR.
The authors thank CONACyT for the ﬁnancial support
provided for this work and all physicians responsible for the
project in the different participating hospitals: Dr. Germán
Castelazo (IMSS, Ciudad de México, DF); Dr. Sinhué Barroso
Bravo (IMSS, Ciudad de México, DF); Dr. Fernando Mainero
Ratchelous (IMSS, Ciudad de México, DF); Dr. Joaquín Zarco
Méndez (ISSSTE, Ciudad de México, DF); Dr. Edelmiro PérezMarch 2014Rodríguez (Hospital Universitario, Monterrey, Nuevo León);
Dr. Jesús Pablo Esparza Cano (IMSS, Monterrey, Nuevo León);
Dr. Heriberto Fabela (IMSS, Monterrey, Nuevo León); Dr.
Fausto Hernández Morales (ISSSTE, Veracruz, Veracruz);
Dr. Pedro Coronel Brizio (CECAN SS, Xalapa, Veracruz);
Dr. Vicente A. Saldana Quiroz (IMSS, Veracruz); and Dr.
Fiona McKenzie (IARC, Lyon).References
1. World Health Organization. The global burden of disease: 2004
update. www.who.int/healthinfo/global_burden_disease/GBD_report_
2004update_full.pdf.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J
Clin 2011;61(2):69–90.
3. Barquera S, Campos-Nonato I, Hernandez-Barrera L, et al. Obesity and
central adiposity in Mexican adults: results from the Mexican National
Health and Nutrition Survey 2006. Salud Publica Mex 2009;51(S4):
S595–S603.
4. Fagherazzi G, Chabbert-Buffet N, Fabre A, et al. Hip circumference is
associated with the risk of premenopausal ER-/PR- breast cancer. Int J
Obes (Lond) 2012;36(3):431–9.
5. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of
body size in premenopausal breast cancer. Arch Intern Med 2006;166
(21):2395–402.
6. Palmer JR, Campbell LL, Boggs DA, et al. A prospective study of body
size and breast cancer in black women. Cancer Epidemiol Biomarkers
Prev 2007;16(9):1795–802.
7. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence
of cancer: a systematic review and meta-analysis of prospective
observational studies. Lancet 2008;371(9612):569–78.
8. Suzuki R, Orsini N, Saji S, et al. Body weight and incidence of breast
cancer deﬁned by estrogen and progesterone receptor status—a meta-
analysis. Int J Cancer 2009;124(3):698–712.
9. Fagherazzi G, Vilier A, Boutron-Ruault MC, et al. Height, sitting
height, and leg length in relation with breast cancer risk in the E3N
cohort. Cancer Epidemiol Biomarkers Prev 2012;21(7):1171–5.
10. Ogundiran TO, Huo D, Adenipekun A, et al. Case–control study of
body size and breast cancer risk in Nigerian women. Am J Epidemiol
2010;172(6):682–90.
11. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of
prospective cohort studies on height, weight, and breast cancer risk.
Am J Epidemiol 2000;152(6):514–27.
12. Connolly BS, Barnett C, Vogt KN, et al. A meta-analysis of published
literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer
2002;44(2):127–38.
13. Hall IJ, Newman B, Millikan RC, et al. Body size and breast cancer risk
in black women and white women: the Carolina Breast Cancer Study.
Am J Epidemiol 2000;151(8):754–64.
14. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer
risk: a systematic review. Obes Rev 2003;4(3):157–73.
15. Huang Z, Willett WC, Colditz GA, et al. Waist circumference, waist:
hip ratio, and risk of breast cancer in the Nurses’ Health Study. Am J
Epidemiol 1999;150(12):1316–24.
16. Baer HJ, Colditz GA, Rosner B, et al. Body fatness during childhood and
adolescence and incidence of breast cancer in premenopausal women: a
prospective cohort study. Breast Cancer Res 2005;7(3):R314–R325.
17. Baer HJ, Tworoger SS, Hankinson SE, et al. Body fatness at young ages
and risk of breast cancer throughout life. Am J Epidemiol 2010;171
(11):1183–94.
18. Fagherazzi G, Guillas G, Boutron-Ruault MC, et al. Body shape
throughout life and the risk for breast cancer at adulthood in the
French E3N cohort. Eur J Cancer Prev 2013;22(1):29–37.
Amadou et al / Am J Prev Med 2014;46(3S1):S52–S64S6419. John EM, Sangaramoorthy M, Phipps AI, et al. Adult body size,
hormone receptor status, and premenopausal breast cancer risk in a
multiethnic population: the San Francisco Bay Area breast cancer
study. Am J Epidemiol 2011;173(2):201–16.
20. Magnusson CM, Roddam AW. Breast cancer and childhood anthrop-
ometry: emerging hypotheses? Breast Cancer Res 2005;7(3):83.
21. Weiderpass E, Braaten T, Magnusson C, et al. A prospective study of
body size in different periods of life and risk of premenopausal breast
cancer. Cancer Epidemiol Biomarkers Prev 2004;13(7):1121–7.
22. Baumgartner KB, Hunt WC, Baumgartner RN, et al. Association of
body composition and weight history with breast cancer prognostic
markers: divergent pattern for Hispanic and non-Hispanic White
women. Am J Epidemiol 2004;160(11):1087–97.
23. Wenten M, Gilliland FD, Baumgartner K, et al. Associations of
weight, weight change, and body mass with breast cancer risk in
Hispanic and non-Hispanic white women. Ann Epidemiol 2002;
12(6):435–4.
24. Sexton KR, Franzini L, Day RS, et al. A review of body size and breast
cancer risk in Hispanic and African American women. Cancer
2011;117(23):5271–81.
25. del Rio-Navarro BE, Velazquez-Monroy O, Sanchez-Castillo CP, et al.
The high prevalence of overweight and obesity in Mexican children.
Obes Res 2004;12(2):215–23.
26. Angeles-Llerenas A, Ortega-Olvera C, Perez-Rodriguez E, et al. Mod-
erate physical activity and breast cancer risk: the effect of menopausal
status. Cancer Causes Control 2010;21(4):577–86.
27. Beasley JM, Coronado GD, Livaudais J, et al. Alcohol and risk of breast
cancer in Mexican women. Cancer Causes Control 2010;21(6):863–70.
28. Hernandez-Avila M, Romieu I, Parra S, et al. Validity and reprodu-
cibility of a food frequency questionnaire to assess dietary intake of
women living in Mexico City. Salud Publica Mex 1998;40(2):133–40.
29. Lohman TG, Roche AF, Martorell R, eds. Anthropometric stand-
ardization reference manual, 1988. Champaign IL: Human Kinetics,
2013. ISBN-13: 978-0873221214.
30. Tehard B, van Liere MJ, Com NC, et al. Anthropometric measure-
ments and body silhouette of women: validity and perception. J Am
Diet Assoc 2002;102(12):1779–84.
31. Jones B, Nagin D, Roglic G. A SAS procedure based on mixture models
for estimating developmental trajectories. Sociol Met Res 2013;374–93.
32. Nagin D. Analyzing developmental trajectories: a semiparametric,
group-based approach. Psychol Methods 2013;4(No 2):139–57.
33. Jones B, Nagin D. Advances in group-based trajectory modeling and a
SAS procedure for estimating them. Sociol Methods Res 2013:542–71.
34. Slattery ML, Sweeney C, Edwards S, et al. Body size, weight change, fat
distribution and breast cancer risk in Hispanic and non-Hispanic white
women. Breast Cancer Res Treat 2007;102(1):85–101.
35. Manders P, Pijpe A, Hooning MJ, et al. Body weight and risk of breast
cancer in BRCA1/2 mutation carriers. Breast Cancer Res Treat 2011;
126(1):193–202.36. Sarkissyan M, Wu Y, Vadgama JV. Obesity is associated with breast
cancer in African-American women but not Hispanic women in South
Los Angeles. Cancer 2011;117(16):3814–23.
37. Shin A, Matthews CE, Shu XO, et al. Joint effects of body size, energy
intake, and physical activity on breast cancer risk. Breast Cancer Res
Treat 2009;113(1):153–61.
38. Shu XO, Jin F, Dai Q, et al. Association of body size and fat distribution
with risk of breast cancer among Chinese women. Int J Cancer 2001;94
(3):449–55.
39. Sangaramoorthy M, Phipps AI, Horn-Ross PL, et al. Early-life factors
and breast cancer risk in Hispanic women: the role of adolescent body
size. Cancer Epidemiol Biomarkers Prev 2011;20(12):2572–82.
40. Berstad P, Coates RJ, Bernstein L, et al. A case–control study of body
mass index and breast cancer risk in white and African-American
women. Cancer Epidemiol Biomarkers Prev 2010;19(6):1532–44.
41. Bardia A, Vachon CM, Olson JE, et al. Relative weight at age 12 and
risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers
Prev 2008;17(2):374–8.
42. White KK, Park SY, Kolonel LN, et al. Body size and breast cancer risk:
the Multiethnic Cohort. Int J Cancer 2012;131(5):E705–E716.
43. Tehard B, Clavel-Chapelon F. Several anthropometric measurements
and breast cancer risk: results of the E3N cohort study. Int J Obes
(Lond) 2006;30(1):156–63.
44. Wacker M, Risendal B, Westerlind K, et al. Ethnicity, body size, and
estrogen levels in postmenopausal Hispanic and non-Hispanic white
women. J Womens Health (Larchmt ) 2009;18(4):487–91.
45. Setiawan VW, Haiman CA, Stanczyk FZ, et al. Racial/ethnic differences
in postmenopausal endogenous hormones: the multiethnic cohort
study. Cancer Epidemiol Biomarkers Prev 2006;15(10):1849–55.
46. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological
evidence and proposed mechanisms. Nat Rev Cancer 2004;4(8):
579–91.
47. Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast
cancer in postmenopausal women: reanalysis of nine prospective
studies. J Natl Cancer Inst 2002;94(8):606–16.
48. Key TJ, Appleby PN, Reeves GK, et al. Insulin-like growth factor 1
(IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled
individual data analysis of 17 prospective studies. Lancet Oncol
2010;11(6):530–42.
49. Rinaldi S, Peeters PH, Berrino F, et al. IGF-I, IGFBP-3 and breast cancer
risk in women: the European Prospective Investigation into Cancer and
Nutrition (EPIC). Endocr Relat Cancer 2006;13(2):593–605.
50. Slattery ML, Baumgartner KB, Byers T, et al. Genetic, anthropometric,
and lifestyle factors associated with IGF-1 and IGFBP-3 levels in
Hispanic and non-Hispanic white women. Cancer Causes Control
2005;16(10):1147–57.
51. Must A, Phillips SM, Naumova EN, et al. Recall of early menstrual
history and menarcheal body size: after 30 years, how well do women
remember? Am J Epidemiol 2002;155(7):672–9.www.ajpmonline.org
